(VIANEWS) – REC SILICON (RECSI.OL), PGS (PGS.OL), AIRBUS (AIR.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. REC SILICON (RECSI.OL)
139.5% sales growth and 70.93% return on equity
REC Silicon ASA, together with its subsidiaries, produces and sells silicon materials for the solar and electronics industries worldwide. It offers various Signature Silane gas, a pure form of silicon that produces product for fuel industries comprising specialty gases, including Dichlorosilane, Monochlorosilane, and Disilane for use in the manufacturing processes of flat panel displays, semiconductors, and solar cells; solar grade polysilicon, including NextSi used for multi crystalline and monocrystalline solar ingot and wafer production in the manufacturing of solar modules; and electronic grade polysilicon consisting of float zone-based devices are used in motor control and power conversion processes for hybrid and electric vehicles, wind energy, and high voltage transmission, 5G communications, high-speed trains, internet of things, and big data, as well as Czochralski for manufacturing of semiconductor wafers used in memory processors, optics, and micro electromechanical systems. The company was formerly known as Renewable Energy Corporation ASA and changed its name to REC Silicon ASA in October 2013. REC Silicon ASA was founded in 1996 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, REC SILICON has a trailing twelve months EPS of kr0.76.
PE Ratio
REC SILICON has a trailing twelve months price to earnings ratio of 12.23. Meaning, the purchaser of the share is investing kr12.23 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.93%.
Volume
Today’s last reported volume for REC SILICON is 788631 which is 56.68% below its average volume of 1820590.
Sales Growth
REC SILICON’s sales growth is 111.7% for the ongoing quarter and 139.5% for the next.
Moving Average
REC SILICON’s worth is way under its 50-day moving average of kr10.47 and way below its 200-day moving average of kr13.08.
More news about REC SILICON.
2. PGS (PGS.OL)
50.4% sales growth and 8.65% return on equity
PGS ASA, together with its subsidiaries, operates as a marine geophysical company in Norway and internationally. The company provides a range of seismic and reservoir services, including data acquisition, imaging, interpretation, and field evaluation to oil and gas companies, as well as carbon storage and offshore wind markets. The company was formerly known as Petroleum Geo-Services ASA and changed its name to PGS ASA in May 2019. PGS ASA was founded in 1991 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PGS has a trailing twelve months EPS of kr0.4.
PE Ratio
PGS has a trailing twelve months price to earnings ratio of 21.43. Meaning, the purchaser of the share is investing kr21.43 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.65%.
Yearly Top and Bottom Value
PGS’s stock is valued at kr8.57 at 02:20 EST, way below its 52-week high of kr10.44 and way above its 52-week low of kr4.95.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 566.7% and 310%, respectively.
More news about PGS.
3. AIRBUS (AIR.PA)
30.3% sales growth and 35.7% return on equity
Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides helicopter-related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; missile and space launcher systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is headquartered in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €4.97.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 31.97. Meaning, the purchaser of the share is investing €31.97 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.7%.
Moving Average
AIRBUS’s worth is way above its 50-day moving average of €133.39 and way above its 200-day moving average of €129.25.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 63.2B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 19.6% and positive 13.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AIRBUS’s EBITDA is 54.62.
More news about AIRBUS.
4. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 19.84% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 17.72. Meaning, the purchaser of the share is investing kr17.72 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr22.50 at 02:20 EST, way below its 52-week high of kr25.10 and higher than its 52-week low of kr20.60.
More news about VISTIN PHARMA.
5. VERALLIA (VRLA.PA)
6% sales growth and 46.92% return on equity
Verallia Société Anonyme manufactures and sells glass packaging products for beverages and food products worldwide. It provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.01.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.99. Meaning, the purchaser of the share is investing €8.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.92%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 14, 2024, the estimated forward annual dividend rate is 2.15 and the estimated forward annual dividend yield is 5.74%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 3.9B for the twelve trailing months.
Yearly Top and Bottom Value
VERALLIA’s stock is valued at €36.04 at 02:20 EST, way under its 52-week high of €44.86 and way higher than its 52-week low of €29.56.
Moving Average
VERALLIA’s value is higher than its 50-day moving average of €35.64 and above its 200-day moving average of €35.20.
More news about VERALLIA.
